Artículos de revistas
Impact of early valve surgery on outcome of staphylococcus aureus prosthetic valve infective endocarditis: Analysis in the international collaboration of endocarditis-prospective cohort study
Fecha
2015Registro en:
Clinical Infectious Diseases, Volumen 60, Issue 5, 2018, Pages 741-749
15376591
10584838
10.1093/cid/ciu871
Autor
Chirouze, Catherine
Alla, François
Fowler, Vance G.
Sexton, Daniel J.
Corey, G. Ralph
Chu, Vivian H.
Wang, Andrew
Erpelding, Marie Line
Durante-Mangoni, Emanuele
Fernández-Hidalgo, Nuria
Giannitsioti, Efthymia
Hannan, Margaret M.
Lejko-Zupanc, Tatjana
Mir
Institución
Resumen
© The Author 2014. Background. The impact of early valve surgery (EVS) on the outcome of Staphylococcus aureus (SA) prosthetic valve infective endocarditis (PVIE) is unresolved. The objective of this study was to evaluate the association between EVS, performed within the first 60 days of hospitalization, and outcome of SA PVIE within the International Collaboration on Endocarditis-Prospective Cohort Study. Methods. Participants were enrolled between June 2000 and December 2006. Cox proportional hazards modeling that included surgery as a time-dependent covariate and propensity adjustment for likelihood to receive cardiac surgery was used to evaluate the impact of EVS and 1-year all-cause mortality on patients with definite left-sided S. aureus PVIE and no history of injection drug use. Results. EVS was performed in 74 of the 168 (44.3%) patients. One-year mortality was significantly higher among patients with S. aureus PVIE than in patients with non-S. aureus PVIE (48.2% vs 32.9%; P =